Skip to main content

  • COVID-19 And 3D Printing

    17 Apr, 2020

    A couple of months ago, my colleague Chris Cunnane - a Research Director in Supply Chain Management at ARC Advisory Group - wrote an article about 3D printing and the supply chain, looking at how additive manufacturing can and will impact the end to end global supply chain. He looked at how companies are beginning to explore on-demand manufacturing rather than traditional manufacturing models, meaning they can keep less physical inventory on-hand. Using a digital representation of parts a...
  • Body Temperature Assessment

    17 Apr, 2020
    This video covers how to assess body temperature focusing on Oral, Rectal, Axilliary, Tympanic and Temporal artery temperature procedures. It also takes into account special populations such as the infants and the elderlies. 

  • WHO's Facebook Messenger Chatbot to combat COVID-19 misinformation

    17 Apr, 2020

    In an effort to better inform the world about CODIV-19, the WHO has launched a Facebook Messenger version of its WHO Health Alert platform – offering instant and accurate information about COVID-19– via Facebook’s global reach.




    The WHO’s Health Alert interactive service can now be accessed in English, French, Spanish, and Arabic through WHO’s official Facebook page by selecting “Send Message” or through the dedicated Messenger link.




    The WHO Health Ale...
  • Imaging Features of COVID-19

    17 Apr, 2020
    Osmosis provides some tips and explanations related to the diagnosis of COVID-19 by imaging. 

  • Asthma Is Absent Among Top Covid-19 Risk Factors, Early Data Shows

    17 Apr, 2020
    Despite warnings that asthmatics were at higher risk for severe illness from the coronavirus, asthma is showing up in only about five percent of New York State’s fatal Covid cases.

    For people with asthma, the outbreak of a pandemic that can lead to respiratory failure has not been a welcome event. Many health organizations have cautioned that asthmatics are most likely at higher risk for severe illness if they get the coronavirus. There’s been a run on inhalers, and coronavirus patient...
  • Roche joins race to make coronavirus antibody tests

    17 Apr, 2020
    Swiss drugmaker Roche aims by next month to offer blood tests to identify those who had been infected with the coronavirus, potentially helping inform locked-down nations of who might have some immunity and be able to resume work or contact with the public. 

    The Basel-based company said on Friday it wants to make the antibody test available by early May in countries that accept European CE regulatory standards, and is seeking U.S. Food and Drug Administration emergency authorization fo...
  • Healthcare workers 'should be screened for Covid-19 every week'

    17 Apr, 2020
    UK cancer specialist says leaving potentially infectious staff in hospitals is unethical.

    Healthcare workers should be screened for Covid-19 every week to protect patients from asymptomatic infection, the head of the Francis Crick Institute’s testing facility has said.

    The call comes amid concerns that hospitals are becoming hotspots for disease transmission and evidence that a significant fraction of those infected show few or no symptoms.

    “For all our fuss about social ...
  • Covid-19 patients recovering quickly after getting experimental drug remdesivir

    17 Apr, 2020

    Covid-19 patients who are getting an experimental drug called remdesivir have been recovering quickly, with most going home in days, STAT News reported Thursday after it obtained a video of a conversation about the trial.
    The patients taking part in a clinical trial of the drug have all had severe respiratory symptoms and fever, but were able to leave the hospital after less than a week of treatment, STAT quoted the doctor leading the trial as saying."The best news is that most of our ...
  • Antibiotic treatment for COVID-19 complications could fuel resistant bacteria

    17 Apr, 2020
    In her regular job, Priya Nori runs Montefiore Medical Center’s antibiotic stewardship program, and spends most of her time ensuring that the Bronx-based hospital doesn’t overuse the drugs and allow bacteria resistant to them to thrive. But like many physicians, Nori is now spending all of her time helping treat COVID-19 patients at her New York City hospital, which like other medical centers in the pandemic hot spot, is crowded with 50% more patients than normal. As part of that care, she an...
  • Solar-powered hand sanitiser wins ESA-backed hackathon

    17 Apr, 2020
    The disinfection station uses light at wavelengths demonstrated to kill germs but to be safe for skin and eye contact. It was presented by SunCrafter, a German start-up business that uses modules decommissioned by industrial solar farms to provide power to remote communities.



    Lisa Wendzich, founder and chief executive, said that the company – which is based on the Siemens innovation campus in Berlin – was now working with partners to identify how to manufacture significant numb...
  • BlueDot

    17 Apr, 2020

    BlueDot’s outbreak risk software safeguards lives by mitigating exposure to infectious diseases that threaten human health, security, and prosperity.






    BlueDot was among the first in the world to identify the emerging risk from COVID-19 in Hubei province and notify our clients via our Insights platform, validating our capabilities as a global early warning system for infectious disease.

    BlueDot published the first scientific paper on COVID-19, accurately pr...
  • Computational predictions of protein structures associated with COVID-19

    17 Apr, 2020

    The scientific community has galvanised in response to the recent COVID-19 outbreak, building on decades of basic research characterising this virus family. Labs at the forefront of the outbreak response shared genomes of the virus in open access databases, which enabled researchers to rapidly develop tests for this novel pathogen. Other labs have shared experimentally-determined and computationally-predicted structures of some of the viral proteins, and still others have shared epidemiol...